Skip to main content

Bench-to-Bedside Program

Partner Offices

Funding for Bench-to-Bedside Awards is provided in the following research categories by the entities listed below:

(1) AIDS (Support from the Office of AIDS Research): Exemplary HIV/AIDS projects aligned with the new overarching HIV/AIDS research priorities will be considered for funding (https://www.oar.nih.gov/hiv-policy-and-research/research-priorities).

(2) Behavioral and Social Sciences (Support from the NIH Office of Behavioral and Social Sciences Research): Projects will be considered for funding that facilitate the translation of basic behavioral and social science research findings into effective interventions to prevent disease and to promote and optimize health. Of particular interest are interdisciplinary research and systems thinking and modeling approaches that integrate multiple levels of analysis - from cells to society - of factors that influence health. Key problems in population health where scientists, practitioners, and decision-makers can work together to accelerate the translation, implementation, dissemination, and adoption of behavioral and social sciences research findings are of high priority to OBSSR. The Office has strong interests in the development of behavioral interventions to improve health, studies of gene-environment interactions, adherence (at the patient and provider levels), measurement harmonization, primary care, mobile health, health disparities, shared medical decision-making, the exposome, and other areas.

(3) Dietary Supplements (Support from the Office of Dietary Supplements): Awards in this funding category are designed to promote scientific study of the benefits of dietary supplements in maintaining health and preventing chronic disease and other health-related conditions but not in disease treatment. In the U.S., these ingredients are usually defined as including plant extracts, enzymes, vitamins, minerals, amino acids, and hormonal products that are available without prescription and are consumed in addition to the regular diet.

(4) Healthy Disparities and Minority Health (Support from the National Institute on Minority Health & Health Disparities): NIMHD will fund projects that support the overall NIH effort to reduce and ultimately eliminate health disparities, improve minority health and promote health equity. Research projects must focus on: 1) improving our understanding of ways to reduce health disparities among racial/ethnic minorities, persons of less privileged socioeconomic status, sexual gender minorities, or underserved rural residents; or 2) health determinants and mechanisms of health outcomes in racial/ethnic minority populations as defined by the US Census.

(5) Rare Diseases (Support from Office of Rare Diseases Research in the National Center for Advancing Translational Sciences): ORDR/NCATS will provide funding in this category. Projects must focus on an area of science/research directly related to a rare disease. An orphan or rare disease is generally considered to have a prevalence of less than 200,000 affected individuals in the United States. Diseases with a prevalence of more than 200,000 affected individuals may be included if a biologically plausible subset of the disease, with a prevalence less than 200,000, can be scientifically justified for focused research. A comprehensive list of rare diseases, updated regularly, is available at http://rarediseases.info.nih.gov/RareDiseaseList.aspx?PageIC=1.

(6) Women's Health (Support from the Office of Research on Women's Health): One project will be funded that focuses on efforts to improve the health of women through biomedical and behavioral research. The influence of sex and gender on health and disease is of particular interest, specifically comparing and contrasting female and male data from cells, animals, or tissues across a range of research questions. For information on the Trans-NIH Strategic Plan for Women’s Health Research, see: www.nih.gov/women/strategicplan.

(7) General: ll projects that are not funded by the Donor Offices as well as additional meritorious projects that don't fall within the scope of the categories listed above will be considered for funding in the "general" category. These projects are funded using Stable Funds provided by the NIH Director.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 05/01/2019

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at http://www.cc.nih.gov/disclaimers.html